HIGH EXPRESSION OF C-MET WITH WIDE TYPE EGFR MUTATION IDENTIFY A DISTINCT SUBSETS INDICATIVE POOR PROGNOSIS IN PATIENTS WITH NSCLC

被引：0
|
作者：
Huang, Ling [1 ]
An, She J. [1 ]
Chen, Zhi H. [1 ]
Su, Jian [1 ]
Xie, Zhi [1 ]
Yan, Hong H. [1 ]
Zhang, Xu C. [1 ]
Huang, Ying [1 ]
Chen, Shi L. [1 ]
Guo, Wei B. [1 ]
Wu, Yi-long [1 ]
机构：
[1] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Lung Canc Inst, Pulm Oncol, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-050
引用
收藏
页码：S470 / S470
页数：1
相关论文
共 50 条
  • [21] c-Met Expression Is a Marker of Poor Prognosis in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Chemoradiation
    Baschnagel, Andrew M.
    Williams, Lindsay
    Hanna, Alaa
    Chen, Peter Y.
    Krauss, Daniel J.
    Pruetz, Barbara L.
    Akervall, Jan
    Wilson, George D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (03): : 701 - 707
  • [22] Tumor c-Met expression and prognosis of advanced hepatocellular carcinoma patients treated with sorafenib
    Shao, Yu Yun
    Hsiao, Chi-Huang
    Lee, Ray
    Puig, Oscar
    Chan, Soa-Yu
    Li, Yong-Shi
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [23] High expression of Cullin1 indicates poor prognosis for NSCLC patients
    Xu, Mingming
    Yang, Xiaoming
    Zhao, Jinli
    Zhang, Jianguo
    Zhang, Shu
    Huang, Hua
    Liu, Yifei
    Liu, Junhua
    PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (07) : 397 - 401
  • [24] High Expression of c-Met, PKCλ and ALDH1A3 Predicts a Poor Prognosis in Late- stage Breast Cancer
    Motomura, Hitomi
    Nozaki, Yuka
    Onaga, Chotaro
    Ozaki, Ayaka
    Tamori, Shoma
    Shiina, Taka-Aki
    Kanai, Shotaro
    Ohira, Chihiro
    Hara, Yasushi
    Harada, Yohsuke
    Takasawa, Ryoko
    Hanawa, Takehisa
    Tanuma, Sei-Ichi
    Mano, Yasunari
    Sato, Tsugumichi
    Sato, Keiko
    Akimoto, Kazunori
    ANTICANCER RESEARCH, 2020, 40 (01) : 35 - 52
  • [25] High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis
    Neuzillet, Cindy
    Couvelard, Anne
    Tijeras-Raballand, Annemilai
    de Mestier, Louis
    de Gramont, Armand
    Bedossa, Pierre
    Paradis, Valerie
    Sauvanet, Alain
    Bachet, Jean-Baptiste
    Ruszniewski, Philippe
    Raymond, Eric
    Hammel, Pascal
    Cros, Jerome
    HISTOPATHOLOGY, 2015, 67 (05) : 664 - 676
  • [26] HGF/c-met expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and an aggressive phenotype
    Kaposi-Novak, Pal
    Lee, Ju-Seog
    Gomez-Quiroz, Luis
    Coulouarn, Cedric
    Factor, Valentina M.
    Thorgeirsson, Snorri S.
    CANCER RESEARCH, 2006, 66 (08)
  • [27] PDX from the naive NSCLC patients containing activating EGFR mutations are resistant to erlotinib but sensitive to c-met inhibitor
    Yang, Mengmeng
    Deng, Jiangyun
    Song, Xiaoming
    Cai, Jie
    Chen, Taiping
    Chen, Yiyou
    Li, Henry Q. X.
    CANCER RESEARCH, 2012, 72
  • [28] Comparative assessment of c-MET expression on circulating tumour cells and tumour tissue from patients with NSCLC
    Ilie, M.
    Hofman, V.
    Long-Mira, E.
    Bence, C.
    Butori, C.
    Lalvee, S.
    Selva, E.
    Marquette, C. H.
    Hofman, P.
    VIRCHOWS ARCHIV, 2014, 465 : S46 - S46
  • [29] A PROSPECTIVE OBSERVATIONAL STUDY EVALUATING C-MET EXPRESSION AND EGFR GENE MUTATION CORRELATION WITH ERLOTINIB RESPONSE IN 2ND LINE TREATMENT FOR ADVANCED/METASTATIC NSCLC PATIENTS - INTERIM ANALYSIS
    Oh, I-J
    Choi, Y-D
    Song, S-Y
    Choi, S.
    Shin, H-J
    Park, C-K
    Lee, B-R
    Ban, H-J
    Kwon, Y-S
    Kim, K-S
    Kim, Y-Il
    Lim, S-C
    Kim, Y-C
    Yoon, S-H
    RESPIROLOGY, 2014, 19 : 159 - 159
  • [30] PD-L1 Expression Predicts Prognosis in Completely Resected NSCLC Patients with an EGFR Mutation
    Qi, Y. F.
    Qiu, Z. B.
    Wu, Y. L.
    Zhong, W. Z.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S204 - S205
12345